XTNT: Xtant Medical Holdings, Inc. Company Cumulative Debt

Risks for Xtant Medical Holdings (XTNT) are linked to biomaterial cost inflation and the volume of scheduled surgeries in the US. This daily chart from the GURU.Markets platform shows the company's debt, where 0.03 forms the current metric value. The business relies on hospital product approvals and distribution reach. FDA certifications, patents, and the necessity of training surgeons to work with implants create high barriers to entry.

Xtant Medical Holdings (XTNT) is developing a comprehensive bone regeneration system by combining bio-implants with spinal instrumentation. The total amount of borrowed funds, reflected through the volume of debt capital, captures the issuer's actual financial obligations, allowing investors to assess solvency and default risk, as excessive leverage inevitably increases the probability of a decline in the company's share price.